| 000 | 01876 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514213404.0 | ||
| 264 | 0 | _c20050628 | |
| 008 | 200506s 0 0 eng d | ||
| 022 | _a1046-6673 | ||
| 024 | 7 |
_a10.1681/ASN.2004050392 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLassila, Markus | |
| 245 | 0 | 0 |
_aImatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice. _h[electronic resource] |
| 260 |
_bJournal of the American Society of Nephrology : JASN _cFeb 2005 |
||
| 300 |
_a363-73 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aApolipoproteins E |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 | _aBiopsy, Needle |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xdrug therapy |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aKidney Function Tests |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aPiperazines _xpharmacology |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 |
_aReceptor, Platelet-Derived Growth Factor beta _xdrug effects |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xdrug effects |
| 700 | 1 | _aJandeleit-Dahm, Karin | |
| 700 | 1 | _aSeah, Kwee K | |
| 700 | 1 | _aSmith, Craig M | |
| 700 | 1 | _aCalkin, Anna C | |
| 700 | 1 | _aAllen, Terri J | |
| 700 | 1 | _aCooper, Mark E | |
| 773 | 0 |
_tJournal of the American Society of Nephrology : JASN _gvol. 16 _gno. 2 _gp. 363-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1681/ASN.2004050392 _zAvailable from publisher's website |
| 999 |
_c15305726 _d15305726 |
||